|
|
Other links at Articles > Pharmacists |
| 1. |
Promise Dimmed for Toll-Like Receptor 9 Agonist for Lung Cancer
|
|
|
A novel Toll-like receptor 9 (TLR9) agonist, PF-3512676, improved objective responses to standard chemotherapy in a phase 2 study of patients with advanced-stage non-small-cell lung cancer (NSCLC), according to a report in the August 20th Journal of Clinical Oncology. Reuters Health Information
|
| 2. |
Beta-Blocker Therapy Important in Patients Hospitalized With Heart Failure
|
|
|
Continuation of beta-blocker therapy among patients hospitalized for decompensated heart failure is associated with markedly better outcomes compared to heart failure patients in whom beta-blocker therapy is stopped or never started, according to a study published July 15 in the Journal of the American College of Cardiology. Reuters Health Information
|
|
|